New combo therapy aims to shrink tough lung tumors
NCT ID NCT06623136
First seen Nov 01, 2025 · Last updated May 08, 2026 · Updated 21 times
Summary
This study tests a new drug (ES102) combined with an immunotherapy (toripalimab) in 40 adults with advanced non-small cell lung cancer that has not responded to prior treatments. The goal is to see if the combination can shrink tumors or stop them from growing. Participants must not have certain gene mutations and must be between 18 and 75 years old.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Chest Hospital, Capital Medical University
RECRUITINGBeijing, Beijing Municipality, China
Contact
Contact
-
Cancer Hospital of Shandong First Medical University (Shandong Cancer Institute, Shandong Cancer Hospital)
NOT_YET_RECRUITINGJinan, Shandong, China
Contact
Contact
-
Henan Cancer Hospital
RECRUITINGZhengzhou, Henan, China
Contact Phone: •••-•••-••••
Contact
-
Jilin Cancer Hospital
RECRUITINGChangchun, Jilin, China
Contact
Contact
-
Shanxi Provincial Cancer Hospital
RECRUITINGTaiyuan, China
Contact
Contact
-
Taizhou Hospital
RECRUITINGTaizhou, China
Contact
Contact
-
The First Affiliated Hospital of He'nan University of Science and Technology
RECRUITINGLuoyang, China
Contact
Contact
-
The First Affiliated Hospital of Nanchang University
NOT_YET_RECRUITINGNanchang, Jiangxi, China
Contact
Contact
-
The First Affiliated Hospital of Zhengzhou University
RECRUITINGZhengzhou, Henan, China
Contact
Contact
Conditions
Explore the condition pages connected to this study.